发明名称 Substituted quinoxalines compounds
摘要 A heterocyclic compound represented by the general formula (1) or a salt thereof:; wherein m, l, and n respectively represent an integer of 1 or 2; X represents —O— or —CH2—; R1 represents hydrogen, a lower alkyl group, a hydroxy-lower alkyl group, a protecting group, or a tri-lower alkylsilyloxy-lower alkyl group; R2 and R3, which are the same or different, each independently represent hydrogen or a lower alkyl group; or R2 and R3 are bonded to form a cyclo-C3-C8 alkyl group; and R4 represents an aromatic group or a heterocyclic group, wherein the aromatic or heterocyclic group may have one or more arbitrary substituent(s).
申请公布号 US9090572(B2) 申请公布日期 2015.07.28
申请号 US201113822589 申请日期 2011.09.12
申请人 OTSUKA PHARMACEUTICAL CO., LTD. 发明人 Ito Nobuaki;Sasaki Hirofumi;Tai Kuninori;Shinohara Tomoichi
分类号 A61K31/498;C07D241/36;C07D241/42;C07D241/38;C07D243/10;C07D401/04;C07D403/04;C07D403/10;C07D405/04;C07D405/10;C07D409/04;C07D409/10;C07D413/10;C07D417/04;C07D417/10;C07D471/04;C07D491/04;C07D495/04;C07F7/10;C07F7/18;C07D243/12;C07D401/10;C07D498/04 主分类号 A61K31/498
代理机构 Finnegan, Henderson, Farabow, Garrett & Dunner, L.L.P. 代理人 Finnegan, Henderson, Farabow, Garrett & Dunner, L.L.P.
主权项 1. A compound represented by the formula (1) or a pharmaceutically acceptable salt thereof:wherein m is 2, l is 1 and n is 1; X represents —CH2—;R1 represents hydrogen, a C1-C6 alkyl group, a hydroxy C1-C6 alkyl group, a protecting group selected from unsubstituted C1-C6 alkanoyl, phthaloyl, C1-C6 alkoxycarbonyl, unsubstituted aralkyloxycarbonyl, 9-fluorenylmethoxycarbonyl, nitrophenylsulfenyl, aralkyl and C1-C6 alkylsilyl groups, or a tri C1-C6 alkylsilyloxy C1-C6 alkyl group;R2 and R3, which are the same or different, each independently represent hydrogen or a C1-C6 alkyl group; or R2 and R3 are bonded to form a cyclo-C3-C8 alkyl group; andR4 represents any of(1) a phenyl group,(2) an indolyl group,(3) a benzothienyl group,(4) a naphthyl group,(5) a benzofuryl group,(6) a quinolyl group,(7) an isoquinolyl group,(8) a pyridyl group,(9) a thienyl group,(10) a dihydrobenzoxazinyl group,(11) a dihydrobenzodioxinyl group,(12) a dihydroquinolyl group,(13) a chromanyl group,(14) a quinoxalinyl group,(15) a dihydroindenyl group,(16) a dihydrobenzofuryl group,(17) a benzodioxolyl group,(18) an indazolyl group,(19) a benzothiazolyl group,(20) an indolinyl group,(21) a thienopyridyl group,(22) a tetrahydrobenzazepinyl group,(23) a tetrahydrobenzodiazepinyl group,(24) a dihydrobenzodioxepinyl group,(25) a fluorenyl group,(26) a pyridazinyl group,(27) a tetrahydroquinolyl group,(28) a carbazolyl group,(29) a phenanthryl group,(30) a dihydroacenaphthylenyl group,(31) a pyrrolopyridyl group,(32) an anthryl group,(33) a benzodioxinyl group,(34) a pyrrolidinyl group,(35) a pyrazolyl group,(36) an oxadiazolyl group,(38) a tetrahydronaphthyl group,(39) a dihydroquinazolinyl group,(40) a benzoxazolyl group,(41) a thiazolyl group,(42) a quinazolinyl group,(43) a phthalazinyl group,(44) a pyrazinyl group, and(45) a chromenyl group, wherein these aromatic or heterocyclic groups may have 1 to 4 substituent(s) selected from(1-1) a halogen atom,(1-2) a C1-C6 alkyl group,(1-3) a C1-C6 alkanoyl group,(1-4) a halogen-substituted C1-C6 alkyl group,(1-5) a halogen-substituted C1-C6 alkoxy group,(1-6) a cyano group,(1-7) a C1-C6 alkoxy group,(1-8) a C1-C6 alkylthio group,(1-9) an imidazolyl group,(1-10) a tri C1-C6 alkylsilyl group,(1-11) an oxadiazolyl group which may have one or more C1-C6 alkyl group(s),(1-12) a pyrrolidinyl group which may have one or more oxo group(s),(1-13) a phenyl group which may have one or more C1-C6 alkoxy group(s),(1-14) a C1-C6 alkylamino C1-C6 alkyl group,(1-15) an oxo group,(1-16) a pyrazolyl group which may have one or more C1-C6 alkyl group(s),(1-17) a thienyl group,(1-18) a furyl group,(1-19) a thiazolyl group which may have one or more C1-C6 alkyl group(s),(1-20) a C1-C6 alkylamino group,(1-21) a pyrimidyl group which may have one or more C1-C6 alkyl group(s),(1-22) a phenyl C2-C6 alkenyl group,(1-23) a phenoxy group which may have one or more halogen atom(s),(1-24) a phenoxy C1-C6 alkyl group,(1-25) a pyrrolidinyl C1-C6 alkoxy group,(1-26) a C1-C6 alkylsulfamoyl group,(1-27) a pyridazinyloxy group which may have one or more C1-C6 alkyl group(s),(1-28) a phenyl C1-C6 alkyl group,(1-29) a C1-C6 alkylamino C1-C6 alkoxy group,(1-30) an imidazolyl C1-C6 alkyl group,(1-31) a phenyl C1-C6 alkoxy group,(1-32) a hydroxy group,(1-33) a C1-C6 alkoxycarbonyl group,(1-34) a hydroxyl C1-C6 alkyl group,(1-35) an oxazolyl group,(1-36) a piperidyl group,(1-37) a pyrrolyl group,(1-38) a morpholinyl C1-C6 alkyl group,(1-39) a piperazinyl C1-C6 alkyl group which may have one or more C1-C6 alkyl group(s),(1-40) a piperidyl C1-C6 alkyl group,(1-41) a pyrrolidinyl C1-C6 alkyl group,(1-42) a morpholinyl group, and(1-43) a piperazinyl group which may have one or more C1-C6 alkyl group(s).
地址 Tokyo JP